Finland· FI-REL-REL6635
Introna
A interferon alfa-2b product, registered in Finland by Schering-Plough Labo N.V.. The same ATC class is registered in 5 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Interferon alfa-2b is registered in 5 of 19 countries.
Countries holding a registration under ATC L03AB05 (interferon alfa-2b), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 3 of them publish a price we can compare per daily dose
Interferon alfa-2b · ATC L03AB05
5 / 19 countries
- Belgiumprice
- Finlandprice
- Netherlands
- Spainprice
- United Kingdom
The record
At a glance
Fimea (Finland)- Manufacturer
- Schering-Plough Labo N.V.
- Country
- Finland (FI)
- ATC code
- L03AB05
- ATC class
- Interferon alfa-2b
- Defined daily dose
- 2 MIO, E
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
230 interactions on record for interferon alfa-2b.
Graded by severity as the source publishes them — 37 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Interferon alfa-2b · interactions on record
230 records
- 37 severe
- 191 moderate
- 2 minor
Most severe, free to view
- EltrombopagB02BX05severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- ZidovudineJ05AF01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L03AB05
Interferon alfa-2b, as other registers publish it.
- United KingdomInterferon alfa-2b 1million units/ml eye drops preservative freeSpecial Order
- FinlandIntronaSchering-Plough Labo N.V.
- FinlandIntronaMerck Sharp & Dohme Limited
- FinlandIntronaMerck Sharp & Dohme Limited
- FinlandIntronaMerck Sharp & Dohme B.V.
- FinlandIntronaSchering-Plough Labo N.V.
- FinlandIntronaMerck Sharp & Dohme Limited
- FinlandIntronaSchering-Plough Labo N.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3c879566-b77d-473e-9cd6-4eeb7a033cf2 GET /v1/drugs/3c879566-b77d-473e-9cd6-4eeb7a033cf2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "2",
"form": "injektiokuiva-aine",
"route": null,
"ddd_unit": "MU",
"strength": "3 milj.IU",
"atc_label": "interferoni alfa-2b",
"ma_number": "9502",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL6635",
"authorised_at": "1987-06-24"
}See everything about interferon alfa-2b.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.